Cover Image

UTILIZATION OF OPTIMAL MEDICAL PHARMACOTHERAPY IN PATIENTS WITH TYPE 2 DIABETES AND ATHEROSCLEROTIC CARDIOVASCULAR DISEASE: INSIGHTS FROM AN INTEGRATED HEALTHCARE SYSTEM

Therapeutic Area: Pharmacologic Therapy Background: Patients with atherosclerotic cardiovascular disease (ASCVD) and concurrent type 2 diabetes mellitus (T2DM) are at an increased risk for adverse cardiovascular outcomes, and derive significant mortality benefit from secondary prevention therapies....

Full description

Saved in:

Bibliographic Details
Main Authors:	Izza Shahid, MBBS (Author), Budhaditya Bose, MS (Author), Eleonora Avenatti, MD (Author), Safi U. Khan, MD MHS (Author), Mohamad B. Taha, MD (Author), Khurram Nasir, MD MPH MSc (Author)
Format:	Book
Published:	Elsevier, 2023-09-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Gender disparities in utilization of statins for low density lipoprotein management across the spectrum of atherosclerotic cardiovascular disease: Insights from the houston methodist cardiovascular disease learning health system registry
by: Izza Shahid, et al.
Published: (2024)

RELATIONSHIP BETWEEN SOCIOECONOMIC STATUS, CORONARY ARTERY CALCIUM AND ATHEROSCLEROTIC CARDIOVASCULAR DISEASE: A MULTI-COHORT STUDY
by: Taylor Triana, MD, MBA, et al.
Published: (2023)

DIFFERENCES IN LIPOPROTEIN(A) BY RACE, ETHNICITY, AND ATHEROSCLEROTIC CARDIOVASCULAR DISEASE RISK
by: Ramzi Dudum, MD MPH, et al.
Published: (2023)

Impact of Race on Classification of Atherosclerotic Risk Using a National Cardiovascular Risk Prediction Tool
by: Jarett R. Beaudoin, MD, MPH, et al.
Published: (2024)

CHARACTERISTICS AND RISK FACTORS OF YOUNG ATHEROSCLEROTIC CARDIOVASCULAR DISEASE IN AN UNDERREPRESENTED COHORT: INSIGHTS FROM THE ALL OF US RESEARCH PROGRAM
by: Sara J. King, MD
Published: (2024)

Development and validation of a polysocial risk score for atherosclerotic cardiovascular disease
by: Zulqarnain Javed, et al.
Published: (2021)

Practical, Evidence-Based Approaches to Nutritional Modifications to Reduce Atherosclerotic Cardiovascular Disease: An American Society For Preventive Cardiology Clinical Practice Statement
by: Danielle Belardo, MD, et al.
Published: (2022)

Trends in Cardiovascular Deaths Among Young Adults in the United States, 1999-2018
by: Safi U. Khan, MD, et al.
Published: (2020)

Residual Atherosclerotic Cardiovascular Disease Risk: Focus on Non-High-Density Lipoprotein Cholesterol
by: Yonghong Luo MD, et al.
Published: (2023)

Association of cardiovascular risk profile with healthcare expenditure and resource utilization in chronic obstructive pulmonary disease, with and without atherosclerotic cardiovascular disease
by: Zain Jafar, et al.
Published: (2020)

Assessment and management of the heightened risk for atherosclerotic cardiovascular events in patients with lupus erythematosus or dermatomyositis
by: Emily Keyes, BA, et al.
Published: (2021)

Cardiovascular disease in Arab Americans: A literature review of prevalence, risk factors, and directions for future research
by: Hossam Lababidi, MD, et al.
Published: (2024)

SEX DIFFERENCES IN THE ASSOCIATION BETWEEN LIPOPROTEIN (A) AND MYOCARDIAL INFARCTION IN PATIENTS WITH NO ATHEROSCLEROTIC CARDIOVASCULAR DISEASE: THE MASS GENERAL BRIGHAM LP(A) REGISTRY
by: Gurleen Kaur, MD, et al.
Published: (2023)

ATHEROSCLEROTIC CARDIOVASCULAR DISEASE RISK IN UNDERREPRESENTED POPULATIONS: INSIGHTS FROM THE ALL OF US RESEARCH PROGRAM
by: Maaz S. Imam, MsPH
Published: (2024)

Sleep Related Epilepsy and Pharmacotherapy: An Insight
by: Jaya Kumar, et al.
Published: (2018)

Prescribing patterns of evidence-based heart failure pharmacotherapy and outcomes in the ASIAN-HF registry: a cohort study
by: Tiew-Hwa K Teng, PhD, et al.
Published: (2018)

LIPID TRENDS ON DONOR DERIVED ATHEROSCLEROTIC DISEASE AND ALLOGRAFT VASCULOPATHY IN HEART TRANSPLANT RECIPIENTS AT A LARGE ACADEMIC CENTER
by: Antoinette S. Birs, MD, et al.
Published: (2023)

ASSOCIATION OF BODY WEIGHT VARIABILITY AND BODY WEIGHT CHANGE WITH OUTCOMES IN THE SYSTOLIC BLOOD PRESSURE INTERVENTION TRIAL (SPRINT)
by: Richard Kazibwe, MD, MS, et al.
Published: (2023)

Mechanistic Insight into PPARγ and Tregs in Atherosclerotic Immune Inflammation
by: Zhao Gao, et al.
Published: (2021)

EFFECT OF PHYSICAL ACTIVITY ON CLINICAL OUTCOMES IN HIGH-RISK HYPERTENSION. POST-HOC ANALYSIS OF THE SYSTOLIC BLOOD PRESSURE INTERVENTION TRIAL (SPRINT)
by: Richard Kazibwe, MD, MS, et al.
Published: (2023)

Efficacy and Safety for the Achievement of Guideline-Recommended Lower Low-Density Lipoprotein Cholesterol Levels: A Systematic Review and Meta-Analysis
by: Safi U. Khan, MD, et al.
Published: (2020)

THE WEIGHT OF KNOWLEDGE: COMPARING GAMIFICATION VS TRADITIONAL LECTURE IN RESIDENT EDUCATION ON OBESITY MANAGEMENT AND PHARMACOTHERAPY
by: Zohaib Bagha, MD
Published: (2024)

Cardiovascular Risk Profile Among Reproductive-Aged Women in the U.S.: The Behavioral Risk Factor Surveillance System, 2015-2020
by: Ellen Boakye, MD, MPH, et al.
Published: (2024)

LIPOPROTEIN(A) ATHEROSCLEROTIC CARDIOVASCULAR DISEASE RISK SCORE DEVELOPMENT AND PREDICTION IN PRIMARY PREVENTION FROM REAL-WORLD DATA
by: Wenjun Fan, MD, PhD
Published: (2024)

Estimated Aggregate Treatment Benefit With Addition of Multiple Novel Medications for Secondary Prevention of Atherosclerotic Cardiovascular Disease
by: Robert W. Ariss BS, et al.
Published: (2022)

Vorapaxar for Prevention of Major Adverse Cardiovascular and Limb Events in Peripheral Artery Disease
by: Justin T. Morrison MD, et al.
Published: (2022)

US POPULATION QUALIFYING FOR ASPIRIN USE FOR PRIMARY PREVENTION OF CARDIOVASCULAR DISEASE:
by: Athena L. Huang, MD, et al.
Published: (2023)

Newborn Survival Case Study in Rwanda - Bottleneck Analysis and Projections in Key Maternal and Child Mortality Rates Using Lives Saved Tool (LiST)
by: Manpreet Singh Khurmi, MBBS, MPH, et al.
Published: (2017)

Hearing loss patterns throughout life: Insights from Japan
by: Alexandria L. Irace, BA, et al.
Published: (2021)

Development of an Instrument to Measure Patient Perception of the Quality of Nursing Care and Related Hospital Services at the National Hospital of Sri Lanka
by: Upul Senarat, MBBS, MSc, MD, et al.
Published: (2011)

Impact of a Yogic Breathing Technique on the Well-Being of Healthcare Professionals During the COVID-19 Pandemic
by: Divya Kanchibhotla MSc, et al.
Published: (2021)

Houston Methodist cardiovascular learning health system (CVD-LHS) registry: Methods for development and implementation of an automated electronic medical record-based registry using an informatics framework approach
by: Khurram Nasir, et al.
Published: (2024)

Polyneuropathy: A Rare and Challenging Presentation of Essential Mixed Cryoglobulinemia
by: Ahmed Taha MD, et al.
Published: (2021)

Association Between Cardiovascular Health Status and Healthcare Utilization in a Large Integrated Healthcare System
by: Irvin Lien, MD, et al.
Published: (2024)

ASPIRIN FOR PRIMARY PREVENTION IN HIGH-RISK TYPE 2 DIABETES: INSIGHTS FROM THE ACCORD TRIAL
by: Juliana H. Namutebi, MD, MS
Published: (2024)

A simplified approach to identification of risk status in patients with atherosclerotic cardiovascular disease
by: Aparna Sajja, MD, et al.
Published: (2021)

Assessing Social Needs and Engaging Community Health Workers in Underserved Kansas Counties: Insights From Primary Care Providers and Clinic Managers
by: Kristina M. Bridges PhD, et al.
Published: (2023)

Erythrodermic pityriasis rubra pilaris following SARS-CoV-2 vaccination treated with bimekizumab
by: Mysa Saad, MSc, et al.
Published: (2023)

Spontaneous Atraumatic Mediastinal Hemorrhage
by: Morkos Iskander BSc, BMBS, MRCS, PGCertMedEd, et al.
Published: (2013)

Pharmacotherapy against Oxidative Stress in Chronic Kidney Disease: Promising Small Molecule Natural Products Targeting Nrf2-HO-1 Signaling
by: Md Jamal Uddin, et al.
Published: (2021)